The estimated Net Worth of Lisa A Conte is at least $1.44 Million dollars as of 17 May 2024. Ms. Conte owns over 2,695 units of Jaguar Health Inc stock worth over $8,243 and over the last 8 years she sold JAGX stock worth over $0. In addition, she makes $1,433,160 as President, Chief Executive Officer, and Director at Jaguar Health Inc.
Lisa has made over 7 trades of the Jaguar Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she exercised 2,695 units of JAGX stock worth $3,045 on 17 May 2024.
The largest trade she's ever made was exercising 45,000 units of Jaguar Health Inc stock on 5 April 2022 worth over $50,850. On average, Lisa trades about 2,907 units every 101 days since 2016. As of 17 May 2024 she still owns at least 7,295 units of Jaguar Health Inc stock.
You can see the complete history of Ms. Conte stock trades at the bottom of the page.
Lisa A. Conte serves as President, Chief Executive Officer, Director of the Company. Ms. Conte also serves as the Chief Executive Officer and a member of the board of our wholly-owned subsidiary, Napo Pharmaceuticals, Inc. ("Napo"), since she founded the company in November 2001. In 1989, Ms. Conte founded Shaman Pharmaceuticals, Inc., a natural product pharmaceutical company. Ms. Conte is also currently a member of the board of directors of Healing Forest Conservatory, a California not-for-profit public benefit corporation Ms. Conte holds an M.S. in Physiology and Pharmacology from the University of California, San Diego, and an M.B.A. and A.B. in Biochemistry from Dartmouth College.
As the President, Chief Executive Officer, and Director of Jaguar Health Inc, the total compensation of Lisa Conte at Jaguar Health Inc is $1,433,160. There are no executives at Jaguar Health Inc getting paid more.
Lisa Conte is 61, she's been the President, Chief Executive Officer, and Director of Jaguar Health Inc since 2013. There are 6 older and 8 younger executives at Jaguar Health Inc. The oldest executive at Jaguar Health Inc is James Bochnowski, 76, who is the Independent Chairman of the Board.
Lisa's mailing address filed with the SEC is C/O JAGUAR HEALTH, INC., 200 PINE STREET, SUITE 400, SAN FRANCISCO, CA, 94104.
Over the last 10 years, insiders at Jaguar Health Inc have traded over $596,652 worth of Jaguar Health Inc stock and bought 670,772 units worth $1,311,594 . The most active insiders traders include Capital Partners, L.P.Sagar..., James J Bochnowski, and Investments Ltd Burford Cap.... On average, Jaguar Health Inc executives and independent directors trade stock every 66 days with the average trade being worth of $27,901. The most recent stock trade was executed by Pravin R Chaturvedi on 17 May 2024, trading 871 units of JAGX stock currently worth $984.
jaguar health, inc. is a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. our wholly-owned subsidiary, napo pharmaceuticals, inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. our mytesi® (crofelemer) product is approved by the u.s. fda for the symptomatic relief of noninfectious diarrhea in adults with hiv/aids on antiretroviral therapy. canalevia™ is our lead animal prescription drug candidate, intended for treatment of various forms of diarrhea in dogs. equilevia™ is jaguar’s non-prescription product for total gut health in equine athletes. to read our full social media policy, please visit https://jaguar.health/social-media-policy/
Jaguar Health Inc executives and other stock owners filed with the SEC include: